Frequently Asked Questions

MyoSkel AI is an advanced decision support and education platform designed exclusively for orthopedic care teams, including surgeons, trainees, and clinical researchers seeking evidence-based, auditable, and safety-focused AI tools.

MyoSkel AI integrates guideline-based reasoning, a proprietary safety layer, multilingual capabilities, and transparent, auditable recommendations—setting new standards for clinical trust, regulatory readiness, and educational impact.

MyoSkel AI FZ-LLC is headquartered in Dubai Science Park (DSP), the Middle East's leading ecosystem for healthcare and life sciences innovation.

DSP provides access to a world-class network of healthcare organizations, research partners, and regulatory experts. Licensing through DSP ensures MyoSkel AI meets rigorous standards for clinical safety, data privacy, and operational excellence, reinforcing our commitment to quality and global best practices.

MyoSkel AI is currently in the licensing process through Dubai Science Park. Commercial deployment and hospital integration will commence following completion of all required regulatory approvals. Estimated time to complete registration: 3-4 weeks.

Yes. We welcome pilot discussions, platform demonstrations, and early collaborations with hospitals, clinicians, and research organizations. All such engagements are conducted in line with regulatory best practices and will transition to full commercial partnerships upon licensing approval.

All platform features are developed on enterprise-grade, HIPAA-compliant cloud infrastructure, with robust protocols for user authentication, data privacy, and regulatory compliance. No patient-identifiable data is used in any demonstration, pilot, or research context unless fully authorized and compliant with applicable laws.